Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,600.00
Bid: 2,625.00
Ask: 2,635.00
Change: -5.00 (-0.19%)
Spread: 10.00 (0.381%)
Open: 2,630.00
High: 2,645.00
Low: 2,595.00
Prev. Close: 2,605.00
OXIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Group Finance Director

12 Feb 2016 07:00

RNS Number : 8619O
Oxford Instruments PLC
12 February 2016
 

 

Oxford Instruments plc

 

Appointment of Group Finance Director

 

 

Oxford Instruments plc, a leading provider of high-technology tools and systems for industry and research, is pleased to announce the appointment of Gavin Hill as Group Finance Director and to the Board of Directors, effective from 9 May 2016. This follows the announcement on 27 October 2015 of Kevin Boyd's decision to resign from the Group in order to take up the role of Finance Director of Spirax-Sarco Engineering plc on 11 April 2016.

 

Gavin Hill was Group Finance Director of Synergy Health plc from April 2010 until the successful combination with STERIS Corporation on 3 November 2015. He is currently retained to assist with the integration of the two companies. Prior to that he was Corporate Finance Director of Serco Group plc where he held a number of senior finance and commercial positions. Prior to joining Serco, Gavin worked in a variety of finance and corporate treasury roles with Syngenta AG and AstraZeneca plc. Gavin is a Chartered Accountant and an associate member of the Institute of Corporate Treasurers.

 

Nigel Keen, Chairman, said:-

 

"We are delighted with Gavin's appointment as Group Finance Director. He brings excellent financial and listed company credentials, which will make a significant contribution to the future growth of the business and to the Board.

 

"I would also like to thank Kevin for his significant commitment to Oxford Instruments during his nine years with us. He has consistently contributed to the performance and development of the Company and we wish him every success in his new role."

 

 

Gavin Hill commented:

 

"Oxford Instruments is a brand that is recognised around the world for its best-in-class technologies and scientists. It is an honour to be joining such an exceptionally talented team and I look forward to being part of the Group's bright future."

 

 

There are no further details to be disclosed under paragraph 9.6.13 of the Listing Rules.

 

Oxford Instruments expects to announce its results for the year ending 31 March 2016 on 15 June 2016.

 

 

Issued for and on behalf of Oxford Instruments plc

 

 

Enquiries:

 

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

MHP Communications Tel: 020 3128 8100

Rachel Hirst/ Jamie Ricketts

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAKFLFFQLFFBBF
Date   Source Headline
23rd Jan 201410:13 amPRNBlocklisting - Interim Review
22nd Jan 20147:59 amRNSOffer Declared Wholly Unconditional
14th Jan 20145:13 pmPRNHolding(s) in Company
10th Jan 20143:10 pmPRNDirector/PDMR Shareholding
10th Jan 201411:53 amRNSForm 8.5 (EPT/RI)-Andor Technology Plc
10th Jan 20148:15 amRNSOffer Update
8th Jan 20147:00 amRNSExtension Of Offer And Offer Update
6th Jan 20142:35 pmPRNTotal Voting Rights
2nd Jan 20149:47 amPRNDirector/PDMR Shareholding
2nd Jan 20149:26 amPRNHolding(s) in Company
19th Dec 20137:00 amRNSIrrevocable undertakings
17th Dec 201312:57 pmRNSOffer Document for Andor Technology plc
16th Dec 201311:34 amPRNHolding(s) in Company
11th Dec 201310:14 amPRNDirector/PDMR Shareholding
10th Dec 20134:29 pmRNSOffer for Andor Technology plc
9th Dec 20137:00 amRNSStatement re: possible offer by Oxford Instruments
6th Dec 20136:28 pmRNSIncreased proposed offer for Andor Technology plc
5th Dec 20139:36 amPRNAdditional Listing
2nd Dec 20132:37 pmPRNDirector/PDMR Shareholding
2nd Dec 20131:52 pmPRNTotal Voting Rights
2nd Dec 20137:01 amRNSResponse to possible offer from Oxford Instruments
27th Nov 20135:47 pmRNSRe: announcement by Oxford Instruments plc
27th Nov 20132:37 pmRNSUpdate on Possible Offer for Andor Technology plc
20th Nov 20139:45 amPRNForm 8 (OPD) Andor Technology plc
19th Nov 20134:26 pmPRNHolding(s) in Company
18th Nov 201312:00 pmRNSForm 8.3 - [Andor Technology Limited]
13th Nov 20132:36 pmRNSForm 8.3 - [Andor Technology Limited]
12th Nov 20133:06 pmRNSResponse to statement made by Andor Technology plc
12th Nov 20138:23 amRNSResponse to possible offer from Oxford Instruments
12th Nov 20137:01 amRNSStatement re Possible Offer
12th Nov 20137:01 amRNSHalf Yearly Report
4th Nov 20139:17 amPRNTotal Voting Rights
30th Oct 20131:53 pmPRNDirector/PDMR Shareholding
21st Oct 20138:36 amPRNHolding(s) in Company
14th Oct 20134:35 pmRNSNotice of Results
9th Oct 201311:00 amPRNAdditional Listing
1st Oct 20133:18 pmPRNDirector/PDMR Shareholding
1st Oct 20131:11 pmPRNTotal Voting Rights
1st Oct 20138:37 amPRNHolding(s) in Company
30th Sep 201311:37 amPRNHolding(s) in Company
25th Sep 20136:08 pmPRNHolding(s) in Company
25th Sep 20138:21 amPRNHolding(s) in Company
16th Sep 20138:49 amPRNHolding(s) in Company
13th Sep 20138:30 amPRNHolding(s) in Company
11th Sep 201312:33 pmPRNAdditional Listing
11th Sep 201311:07 amPRNResult of AGM
11th Sep 201310:47 amPRNDirectorate Change
10th Sep 20137:00 amRNSAGM Statement
2nd Sep 20132:58 pmPRNTotal Voting Rights
2nd Sep 20139:42 amPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.